Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nigella M, Paula"'
Autor:
Nigella M. Paula, Emerson Joucoski, Valter A. Baura, Emanuel M. Souza, Fabio O. Pedrosa, Alan G. Gonçalves, Luciano F. Huergo
Publikováno v:
Vaccines, Vol 12, Iss 10, p 1149 (2024)
(1) Background: After the COVID-19 pandemic, there is concern regarding the immunity of the population to SARS-CoV-2 variants, particularly the Omicron variant and its sub-lineages. (2) Methods: The study involved analyzing the immune response and sy
Externí odkaz:
https://doaj.org/article/da075a18834f488d988a872bbb0b3846
Autor:
Luciano F. Huergo, Nigella M. Paula, Ana C. A. Gonçalves, Carlos H. S. Kluge, Paulo H. S. A. Marins, Haxley S. C. Camargo, Thamyres P. Sant’Ana, Lucas R. P. Farias, Juliane D. Aldrighi, Ênio S. Lima, Guiomar T. Jacotenski, Letícia R. Vargas, Gisele Costa, Karin V. Weissheimer, Maria G. Nazário, Kádima N. Teixeira, Marcelo S. Conzentino
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 4 (2022)
ABSTRACT The investigation of antibodies raised against different severe acute respiratory syndrome coronavirus (SARS-CoV-2) antigens can help to determine the extent of previous SARS-CoV-2 infections in the population and track the humoral response
Externí odkaz:
https://doaj.org/article/01935af421574979ab7b13a8ccead9f1
Autor:
Nigella M. Paula, Marcelo S. Conzentino, Ana C. A. Gonçalves, Renata da Silva, Karin V. Weissheimer, Carlos H. S. Kluge, Paulo H. S. A. Marins, Haxley S. C. Camargo, Lucas R. P. Farias, Thamyres P. Sant’Ana, Letícia R. Vargas, Juliane D. Aldrighi, Ênio S. Lima, Guiomar T. Jacotenski, Fabio O. Pedrosa, Alan G. Gonçalves, Emerson Joucoski, Luciano F. Huergo
Publikováno v:
Vaccines, Vol 11, Iss 1, p 21 (2022)
(1) Background: COVID-19 vaccination in Brazil has been performed mostly with CoronaVac (Sinovac), ChAdOx1-S (AstraZeneca-University of Oxford) and BNT162b2 (Pfizer-BioNTech) vaccines. The titers of IgG antibodies reactive to the SARS-CoV-2 spike pro
Externí odkaz:
https://doaj.org/article/d03ac3ea489a40ab9464972b56f9b130
Autor:
Marcelo S. Conzentino, Ana C. A. Gonçalves, Nigella M. Paula, Fabiane G. M. Rego, Dalila L. Zanette, Mateus N. Aoki, Jeanine M. Nardin, Luciano Fernandes Huergo
Publikováno v:
Brazilian Journal of Microbiology. 53:1263-1269
Autor:
Nigella M. Paula, Marcelo S. Conzentino, Ana C.A. Gonçalves, Renata da Silva, Karin V. Weissheimer, Carlos H.S. Kluge, Paulo H.S.A. Marins, Haxley S.C. Camargo, Lucas R.P. Farias, Thamyres P. Sant’Ana, Letícia R. Vargas, Juliane D. Aldrighi, Ênio S. Lima, Guiomar T. Jacotenski, Fabio O. Pedrosa, Alan G. Gonçalves, Emerson Joucoski, Luciano F. Huergo
Vaccination is a strategy that confers protection against symptomatic infections and/or development of severe COVID-19. In Brazil, COVID-19 vaccination began in January 2021 and has been performed using vaccines from different manufactures including
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c4e5b6868ae03f0826ef80fd83de640
https://doi.org/10.1101/2022.09.28.22280449
https://doi.org/10.1101/2022.09.28.22280449
Autor:
Marcelo S, Conzentino, Ana C A, Gonçalves, Nigella M, Paula, Fabiane G M, Rego, Dalila L, Zanette, Mateus N, Aoki, Jeanine M, Nardin, Luciano Fernandes, Huergo
Publikováno v:
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]. 53(3)
Immunological assays to detect SARS-CoV-2 Spike Receptor Binding Domain (RBD) antigen seroconversion in humans are important tools to monitor the levels of protecting antibodies in the population in response to infection and/or immunization. Here we